Researchers aim to speed up the process of drug discovery with machine learning and artificial intelligence and minimize the cost. Researchers from the University of Cambridge used the developed algorithms to identify new molecules that activate the protein associated with Alzheimer's disease.

1. MACHINE LEARNING ACCELERATES DRUG DISCOVERY
Tuğçe ARSLAN

2. Drug discovery is a complex and challenging process. Artificial Intelligence (AI) has been
used for drug production in the past years, and studies have been carried out in this field. Stud-
ies have proved that drug discoveries made with Artificial Intelligence (AI) and Machine Learn-
ing (ML) are more efficient and faster than industry standards.
Artificial Intelligence (AI) algorithms occur in many parts of our lives, and studies on the
development of Artificial Intelligence (AI) software continue. Among these studies; are topics
such as face recognition, eye recognition, the location of autonomous vehicles in traffic, and
medical solutions. To ensure success in studies, new algorithms are developed using Big Data,
thousands of data are processed, and reflections on the subject continue.
Researchers aim to speed up the process of drug discovery with Machine Learning (ML)
and Artificial Intelligence (AI) and minimize the cost. For example, researchers from the Uni-
versity of Cambridge used the developed algorithms to identify new molecules that activate the
protein associated with Alzheimer’s disease.
The scenario in the making drugs generally includes four different steps:
• Testing molecular compounds,
• Finding the possible effects of drugs,
• Providing a perspective against the disease,
• Using existing drugs and applying them to existing drugs according to test results.
anumak.ai

3. These steps are repeated in the discovery phase, causing a massive workload in terms of
both time and cost. While these steps are being carried out, each of the compounds utilized is
a candidate for drug development. Some combinations are eliminated during the tests. Work
continues with the remaining compounds. Each step in this process is very costly. For this rea-
son, pharmaceutical companies are incorporating Machine Learning (ML) and Artificial Intelli-
gence (AI) technologies into processes to accelerate drug discovery and reduce drug develop-
ment costs.
From the Cavendish Laboratory in Cambridge, “Machine Learning has made significant
progress in areas like data–abundant computer vision,” says Dr. Alpha Lee. With the algorithm
developed, Dr. Alpha Lee and his colleagues use mathematics a lot in chemical processes in the
stages of drug discovery.
How Are Algorithms Used?
To make the available molecular information usable, researchers first consider the intercon-
nections of each molecule and turn them into graphs with the help of mathematical expressions.
Thus, they obtain different data sets with graphical representations. Then, the algorithm looks at
the active and inactive parts of the molecules used. For the drug, it determines which of these
parts are essential or not.
The algorithm makes predictions about the statistical properties of a noisy dataset, using a
mathematical principle (Arbitrary Matrix Theory); It is then compared with statistics of the chem-
ical properties of the active and inactive molecules found in the tests to decide which chemical
structures are essential and necessary for research. Thus, molecules that have not been success-
ful in previous studies can be used with this technique. At the same time, Artificial Intelligence
(AI) can help test the side effects of candidate drugs.
The researchers built a model that started with 222 active molecules and was able to screen the
molecule. “Finding four active molecules out of six million different molecules is like finding a
needle in a haystack,” Dr. Alpha Lee said. “The comparability provided by the study shows that
our algorithm is twice as efficient as the industry standard,” he said.
We can foresee that Machine Learning (ML) can make the drug discovery process faster
and be used in many different fields in medicine.
The researchers also share that these studies laid the groundwork for chemists trying to make
selections of molecules that would ensure success at the beginning of their studies.
anumak.ai

4. ANUMAK & COMPANY
aNumak & Company is a global management consulting firm, an India private company
limited by warranty. It is a company with expertise in creating scalable business models for
different industry verticals. The Company strives to provide solutions through consulting, digital
transformation, and innovative products that solve modern business problems. Offering on–
site and offshore support and unique strategies, aNumak & Company transforms traditional
business models into high–performance, dynamic, and distinctive business enterprises. It brings
insights from core domain experts to deliver the best possible solutions to drive growth. aNumak
& Company and each of its member firms are legally separate and independent entities. For
more detailed information about aNumak & Company and its member companies, please visit
https://www.anumak.com
This material was prepared by aNumak & Company. This material (including any information it
contains) is intended to provide general information on a particular topic(s). This material may
contain information obtained from publicly available information or other third–party sources.
aNumak & Company does not independently verify such sources and is not responsible for any
loss resulting from reliance on information obtained from such sources. aNumak & Company
does not provide any investment, legal, or other professional advice or services through this
material. You should seek specific advice from the relevant specialist(s) for such services.
This material or information is not intended to be considered the sole basis for any decision
that could affect you, your business, or the operations of the company. Before making any
decision or taking any action that could affect your finances or business, you should consult a
professional.
No institution at aNumak & Company can be held responsible for any loss suffered by any
person or institution due to access to, use, or reliance on this material. By using this material or
any information it contains, the user accepts he entirety of this notice and
the terms of use.
©2022 aNumak & Company
anumak.ai

5. Amith Kumar
Chief Executive Officer,
aNumak & Company
amith@anumak.com
Neha Anush
Chief Operating Officer,
aNumak & Company
neha.anush@anumak.com
Tuǧçe ARSLAN
Chief Content Officer and PR
aNumak & Company
arslan@anumak.in
Cesibel Rodriguez
Chief Branding Officer,
aNumak & Company
cesi@anumak.com
Ricky Devaya
Chief Human Resource Officer – India,
aNumak & Company
ricky@anumak.com
Vilas Khole
Chief Delivery Officer – India,
aNumak & Company
vilas@anumak.com
Karthik Reddy
Chief Sales Officer – UAE,
aNumak & Company
karthik@anumak.in
Iván Muñiz Rothgiesser
Sales Director,
aNumak & Company
ivan@anumak.com
Gino Mori Valenzuela
Client Partner – Retail,
aNumak & Company
gino@anumak.in
Diana Marcela Rios
Client Partner – Retail,
aNumak & Company
diana@anumak.in
aNumak & Company
marketing@anumak.com
Pr@anumak.in - info@anumak.com
Víctor Freundt
Client Partner – Education,
aNumak & Company
victor@anumak.in
Agyemang Mensah Kwadwo
Graphic Designer,
aNumak & Company
agyemang@anumak.in
anumak.ai
CONTACTS CONTRIBUTORS